Publications by authors named "Sepideh Paybast"

Claim this Profile
S
Suboptimal dose of approved disease modifying therapies in management of patients with multiple sclerosis: A systematic review.
Sepideh Paybast, Fatemeh Baghalha, Mohammad Ali Sahraian

Mult Scler Relat Disord· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maternal and neonatal outcomes associated with natalizumab exposure during pregnancy in Iranian patients with multiple sclerosis.
Rozita Doosti, Masoud Ghiasian, Mohammad Ali Sahraian, Kosar Kohandel, Farzad Mehrabi, Sepideh Paybast

Mult Scler Relat Disord· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypogammaglobulinemia and infection risks in multiple sclerosis patients receiving anti-CD20 monoclonal antibodies: Incidence, clinical implications, and longitudinal insights from a three-year Iranian cohort.
Elham Asl Fallah, Ali Emami, Nahid Beladi Moghaddam, Mehran Ghaffari, Fatemeh Meshkini, Sepideh Paybast

Mult Scler Relat Disord· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infection screening prior to Ocrelizumb initiation in patients with Multiple Sclerosis (MS): Concise clinical recommendation based on a modified Delphi consensus on behalf of the Iranian MS -infectious disease group.
Sepideh Paybast, Marzie Abutorabi-Zarchi, Fereshteh Ashtari, Seyyed Mohammad Baghbanian, Nahid Beladi Moghadam

Mult Scler Relat Disord· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dermatologic findings after initiation of fingolimod in patients with multiple sclerosis: A real-world experience of five-year follow-up.
Monireh Samimi, Aida Sajedi, Sepideh Paybast, Nazanin Sadat Nabavi, Shahedeh Karimi

Mult Scler J Exp Transl Clin· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atypical Multiple Sclerosis Overlapping Features of Neuromyelitis Optica Spectrum Disorders (NMOSD).
Sepideh Paybast, Ali Emami, Nasim Rezaeimanesh, Abdorreza Naser Moghadasi

Clin Case Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating treatment alternatives for fingolimod in patients with multiple sclerosis developed refractory fingolimod-related genital Human Papilloma Virus (HPV) infection.
Sepideh Paybast, Fereshteh Ashtari, Nahid Beladi Moghaddam, Maryam Poursadeghfard, Marzie Abutorabi

Mult Scler Relat Disord· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is it time to consider the live attenuated varicella-zoster virus (VZV) vaccination safe in patients with multiple sclerosis treated with natalizumab? An extension study of the first Iranian experience.
Sepideh Paybast, Mohammad Ali Nahayati, Sareh Shahmohammadi, Samira Navardi, Maryam Poursadeghfard

Mult Scler Relat Disord· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of endovascular thrombolysis in patients with acute cerebral venous sinus thrombosis: A systematic review.
Sepideh Paybast, Reza Mohamadian, Ali Emami, Melika Jameie, Fereshteh Shahrab

Interv Neuroradiol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction notice to "The correlation of serum adiponectin and insulin resistance with the presence and severity of dementia in non-obese Alzheimer's patients" [Clin Nutr ESPEN 40C (2020) 376-382/706].
Seyed Amir Hejazi, Kambiz Rohampour, Ehsan Sharifipour, Soruosh Sharifimoghadam, Sepideh Paybast

Clin Nutr ESPEN· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction notice to "Corrigendum to 'The correlation of serum adiponectin and insulin resistance with the presence and severity of dementia in non-obese Alzheimer's patients'" [Clin Nutr ESPEN 53C (2023) 282 / 1590].
Seyed Amir Hejazi, Kambiz Rohampour, Ehsan Sharifipour, Soruosh Sharifimoghadam, Sepideh Paybast

Clin Nutr ESPEN· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
De-escalation of anti-CD20 monoclonal antibodies to low-moderate efficacy disease-modifying treatments (DMTs) in patients with relapse-remitting multiple sclerosis: An initial Iranian experience.
Sepideh Paybast, Nasim Rezaeimanesh, Abdorreza Naser Moghadasi

Caspian J Intern Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dalfampridine in the treatment of primary fatigue in patients with multiple sclerosis: a randomized clinical trail.
Shirin Mavandadi, Sepideh Paybast, Monirsadat Mirzadeh, Hossein Mozhdehipanah

Acta Neurol Belg· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuromyelitis optica spectrum disorders registry system in Iran: Validity of data sets.
Faezeh Khodaie, Mahsa Mohammadi Lapevandani, Yasamin Ebrahimi, Mohammad Ali Sahraian, Abdorreza Naser Moghadasi, Sepideh Paybast

Mult Scler Relat Disord· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pregnant woman with amyotrophic lateral sclerosis from Iran: a case report.
Nooshin Amjadi, Sotoudeh Mohammadi, Sepideh Paybast, Peyman Dadkhah, Maryam Talayeh

Ann Med Surg (Lond)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focal central neurological disorder in patients with autoimmune thyroid disease without encephalopathy.
Parisa Sharifi, Sepideh Paybast, Abdorreza Naser Moghadasi

Clin Case Rep· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New diagnosis of multiple sclerosis in the setting of recent Sinopharm COVID-19 vaccine (BBIBP-CorV) exposure: A series of clinical cases and updated review of the literature.
Sepideh Paybast, Melika Jameie, Mojtaba Shahbazi, Mohammad Amin Habibi, Seyed Ehsan Mohammadianinejad

Curr J Neurol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of the safety of live attenuated varicella-zoster virus vaccination in patients with relapse-remitting multiple sclerosis treated with natalizumab: A case series and review of the literature.
Sepideh Paybast, Mohammad Ali Sahraian, Mohammad Ali Nahayati, Mohammad Amin Habibi, Sareh Shahmohammadi

Mult Scler Relat Disord· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soft Palate Malignant Melanoma as an Adverse Effect of Fingolimod in Multiple Sclerosis: A Case Report and Literature Review.
Hossein Mozhdehipanah, Farshid Safdarian, Sepideh Paybast

Neurol India· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iranian specialists' approach to surgery in patients with multiple sclerosis.
Fereshteh Ghadiri, Zahra Ebadi, Elnaz Asadollahzadeh, Mohammad Ali Sahraian, Amirreza Azimi, Sepideh Paybast

Curr J Neurol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of switching from fingolimod and natalizumab to rituximab in patients with relapsing remitting multiple sclerosis.
Ali Ussama Fakih, Mohammad Ali Sahraian, Sepideh Paybast, Abdorreza Naser Moghadasi

Mult Scler Relat Disord· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and management of multiple sclerosis patients during the Omicron era: is there a concern about the MS course in the face of the new variant of COVID-19?
Sepideh Paybast, Mohammad Amin Habibi, Abdorreza Naser Moghadasi

Neurol Sci· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to 'The correlation of serum adiponectin and insulin resistance with the presence and severity of dementia in non-obese Alzheimer's patients' [Clin Nutr ESPEN 40 (C) (2020) 376-382].
Seyed Amir Hejazi, Kambiz Rohampour, Ehsan Sharifipour, Soruosh Sharifimoghadam, Sepideh Paybast

Clin Nutr ESPEN· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iranian specialists' approach to treatment escalation in multiple sclerosis patients with cognitive impairment.
Fereshteh Ghadiri, Elnaz Asadollahzadeh, Zahra Ebadi, Mohammad Ali Sahraian, Amirreza Azimi, Sepideh Paybast

Curr J Neurol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Watch out for neuromyelitis optica spectrum disorder onset or clinical relapse after COVID-19 vaccination: What neurologists need to know?
Sepideh Paybast, Ali Emami, Fatemeh Baghalha, Abdorreza Naser Moghadasi

Mult Scler Relat Disord· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis